Clinical Trials Logo

Very Low Birth Weight Infants clinical trials

View clinical trials related to Very Low Birth Weight Infants.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03858816 Withdrawn - Clinical trials for Very Low Birth Weight Infants

Efficacy of Multiple Strain Probiotics Reduces the Neurobehavioral Disorder in Premature Very Low Birth Weight Infants

Start date: June 14, 2018
Phase: N/A
Study type: Interventional

The management protocols, clinical practices, equipment, infrastructure, and key personnel in NICU are unchanged during the study period. The data collected by each center are transmitted to the office of the principal investigator (Dr Lin) at China Medical University Hospital. Primary outcome is death or attention deficit and hyperactivity disorder (ADHD) and ASD.

NCT ID: NCT00470743 Withdrawn - Clinical trials for Ductus Arteriosus, Patent

Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies

Start date: May 2007
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine the safety and efficacy of ibuprofen, compared with indomethacin, in the treatment for the closure of the patent ductus arteriosus in premature babies born under 29 weeks gestation

NCT ID: NCT00425581 Withdrawn - Hypotension Clinical Trials

N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life

Start date: February 2007
Phase: N/A
Study type: Observational

The primary objective is to test the hypothesis that there is an association between the hemodynamic status and the serum levels of NT-proBNP and cTnT in prematurely born infants. We would also evaluate the hypothesis that there is an association between the level of these proteins in the serum and the short and long term morbidity.